These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 2676151)

  • 21. Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers.
    Nicholson RI; Colin P; Francis AB; Keshra R; Finlay P; Williams M; Elston CW; Blamey RW; Griffiths K
    Cancer Res; 1986 Aug; 46(8 Suppl):4299s-4302s. PubMed ID: 3524811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid hormone receptors as prognostic indicators in primary breast cancer.
    Thorpe SM; Rose C; Rasmussen BB; King WJ; DeSombre ER; Blough RM; Mouridsen HT; Rossing N; Andersen KW
    Breast Cancer Res Treat; 1986; 7 Suppl():S91-7. PubMed ID: 3527307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of estrogen and prolactin receptor analysis in human breast cancer.
    Waseda N; Kato Y; Imura H; Kurata M
    Jpn J Cancer Res; 1985 Jun; 76(6):517-23. PubMed ID: 2991064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Measurement of estrogen receptor and progesterone receptor in human endometrium and endometrial carcinoma].
    Itoh E
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):812-20. PubMed ID: 2196312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies for progesterone receptor assays and polymorphism studies in breast cancer. Comparison with radioligand assays.
    Goussard J; Magdelenat H; Martin PM; Lechevrel C; Roussel G
    Bull Cancer; 1988; 75(8):771-82. PubMed ID: 3052654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Enzyme immunoassay and radioimmunoassay using monoclonal antibody for the determination of estrogen receptors in human breast cancer].
    Ohnami S; Nakayama C; Ohnami S; Zeze F; Eto S
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3447-52. PubMed ID: 3539025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer.
    Iwase H; Itoh Y; Kuzushima T; Yamashita H; Iwata H; Toyama T; Hara Y; Kobayashi S
    Cancer Detect Prev; 1997; 21(1):29-35. PubMed ID: 9043760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
    Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer.
    Mobbs BG; Johnson IE
    J Steroid Biochem; 1987 Dec; 28(6):653-62. PubMed ID: 3320574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.
    Kurebayashi J; Ishida T; Higashi Y; Suemasu K; Nomoto C; Yoshida K
    Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
    Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
    Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment.
    Søreide JA; Lea OA; Varhaug JE; Skarstein A; Kvinnsland S
    Eur J Surg Oncol; 1992 Apr; 18(2):112-8. PubMed ID: 1582503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of steroid receptors and DNA synthesis in male breast cancer].
    Petroni S; Mangia A; D'Amico C; Simone G
    Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
    Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
    Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers.
    Koenders PG; Beex LV; Geurts-Moespot A; Heuvel JJ; Kienhuis CB; Benraad TJ
    Cancer Res; 1991 Sep; 51(17):4544-8. PubMed ID: 1873798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.
    Reiner A; Neumeister B; Spona J; Reiner G; Schemper M; Jakesz R
    Cancer Res; 1990 Nov; 50(21):7057-61. PubMed ID: 2208173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
    Schenck U; Jütting U; Eiermann W
    Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
    Ciocca DR; Puy LA; Fasoli LC
    Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.
    Ben-David M; Wittliff JL; Fekete M; Kadar T; Biran S; Schally AV
    Biomed Pharmacother; 1988; 42(5):327-34. PubMed ID: 3191209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.